Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?

To: ACAN who wrote (3079)	6/12/2007 12:07:23 AM
From: ~digs	Read Replies (2) \| Respond to of 7944

ISV - InSite Vision Incorporated operates as an ophthalmic product development company in the United States. It engages in the development and commercialization of ophthalmic pharmaceutical products based on DuraSite eyedrop-based drug delivery technology, as well as in the development of genetically-based technologies for the diagnosis, prognosis, and management of glaucoma. The company?s products include AzaSite (ISV-401) for the treatment of bacterial conjunctivitis and other infections of the outer eye; AzaSite Plus (ISV-502) for the treatment of blepharitis, an infection of the eyelid and common eye problems in older adults, as well as other ophthalmic infections; and AzaSite Otic (ISV-016), which is in preclinical stage is used in the treatment for ear infections. It is also developing AquaSite, which is used in the treatment of dry eye; ISV-205 that is used to treat ocular inflammation; ISV?014, a retinal delivery device for the treatment of diabetic retinopathy and macular degeneration; and OcuGene, a glaucoma genetic test. InSite Vision Incorporated has collaborative, licensing, and service agreements with Pfizer, Inc. and Pfizer Products, Inc.; Inspire Pharmaceuticals, Inc.; Cardinal Health PTS, L.L.C.; Bausch and Lomb Incorporated; Societa Industria Farmaceutica Italiana; Quest Diagnostics Incorporated; CIBA Vision Ophthalmics; UC Regents; Columbia Laboratories, Inc.; and SSP Co., Ltd. The company was founded in 1986 and is based in Alameda, California.